Cargando…
A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility
OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasivenes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862357/ https://www.ncbi.nlm.nih.gov/pubmed/27217804 http://dx.doi.org/10.2147/NSS.S103702 |
_version_ | 1782431358345281536 |
---|---|
author | Pavelec, Vaclav Rotenberg, Brian W Maurer, Joachim T Gillis, Edward Verse, Thomas |
author_facet | Pavelec, Vaclav Rotenberg, Brian W Maurer, Joachim T Gillis, Edward Verse, Thomas |
author_sort | Pavelec, Vaclav |
collection | PubMed |
description | OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasiveness of surgical approaches. A new, minimally invasive implant for OSA has been developed, which is elastic and contracts a few weeks after deployment, stabilizing the surrounding soft tissue. The device has had good outcomes in preclinical testing; this report describes the preliminary feasibility and safety of its implementation in humans. PATIENTS AND METHODS: A prospective, multicenter, single-arm feasibility study was conducted. Subjects were adults with moderate-to-severe OSA who had previously failed or refused conventional continuous positive airway pressure treatment. Intraoperative feasibility data, postoperative pain, and safety information were collected for a 30-day postoperative period. RESULTS: Forty subjects participated (37 men, three women; average age of 46.1 years); each received two tongue-base implants and two soft-palate implants. Surgical procedure time averaged 43 minutes. Postsurgical pain resolved readily in most cases; at 30 days post implantation, <20% of subjects reported pain, which averaged less than two out of ten. Adverse events were generally the mild and expected sequelae of a surgical procedure with general anesthesia and intraoral manipulation. The device was well tolerated. Implant extrusions were reported with soft-palate implants (n=12), while tongue-base implants required few revisions (n=2). Quantitative and qualitative sleep effectiveness outcomes (including full-night polysomnographic and quality-of-life measures) will be presented in a subsequent report. CONCLUSION: Implantation of the device was feasible. Although a relatively high rate of extrusions occurred in the now-discontinued palate implants, tongue-base implants were largely stable and well tolerated. The minimally invasive and maintenance-free implant may provide a new alternative to higher morbidity surgical procedures. |
format | Online Article Text |
id | pubmed-4862357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48623572016-05-23 A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility Pavelec, Vaclav Rotenberg, Brian W Maurer, Joachim T Gillis, Edward Verse, Thomas Nat Sci Sleep Original Research OBJECTIVE: Many cases of obstructive sleep apnea (OSA) involve collapse of the tongue base and soft palate during sleep, causing occlusion of the upper airway and leading to oxygen desaturation. Existing therapies can be effective, but they are plagued by patient adherence issues and the invasiveness of surgical approaches. A new, minimally invasive implant for OSA has been developed, which is elastic and contracts a few weeks after deployment, stabilizing the surrounding soft tissue. The device has had good outcomes in preclinical testing; this report describes the preliminary feasibility and safety of its implementation in humans. PATIENTS AND METHODS: A prospective, multicenter, single-arm feasibility study was conducted. Subjects were adults with moderate-to-severe OSA who had previously failed or refused conventional continuous positive airway pressure treatment. Intraoperative feasibility data, postoperative pain, and safety information were collected for a 30-day postoperative period. RESULTS: Forty subjects participated (37 men, three women; average age of 46.1 years); each received two tongue-base implants and two soft-palate implants. Surgical procedure time averaged 43 minutes. Postsurgical pain resolved readily in most cases; at 30 days post implantation, <20% of subjects reported pain, which averaged less than two out of ten. Adverse events were generally the mild and expected sequelae of a surgical procedure with general anesthesia and intraoral manipulation. The device was well tolerated. Implant extrusions were reported with soft-palate implants (n=12), while tongue-base implants required few revisions (n=2). Quantitative and qualitative sleep effectiveness outcomes (including full-night polysomnographic and quality-of-life measures) will be presented in a subsequent report. CONCLUSION: Implantation of the device was feasible. Although a relatively high rate of extrusions occurred in the now-discontinued palate implants, tongue-base implants were largely stable and well tolerated. The minimally invasive and maintenance-free implant may provide a new alternative to higher morbidity surgical procedures. Dove Medical Press 2016-05-04 /pmc/articles/PMC4862357/ /pubmed/27217804 http://dx.doi.org/10.2147/NSS.S103702 Text en © 2016 Pavelec et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Pavelec, Vaclav Rotenberg, Brian W Maurer, Joachim T Gillis, Edward Verse, Thomas A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title | A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title_full | A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title_fullStr | A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title_full_unstemmed | A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title_short | A novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
title_sort | novel implantable device for the treatment of obstructive sleep apnea: clinical safety and feasibility |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862357/ https://www.ncbi.nlm.nih.gov/pubmed/27217804 http://dx.doi.org/10.2147/NSS.S103702 |
work_keys_str_mv | AT pavelecvaclav anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT rotenbergbrianw anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT maurerjoachimt anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT gillisedward anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT versethomas anovelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT pavelecvaclav novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT rotenbergbrianw novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT maurerjoachimt novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT gillisedward novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility AT versethomas novelimplantabledeviceforthetreatmentofobstructivesleepapneaclinicalsafetyandfeasibility |